1-18 of 18
Keywords: Breast cancer
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Journal Articles
Hormone Research (1989) 32 (Suppl. 1): 254–256.
Published Online: 02 December 2008
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Breast cancer Steroid-insensitive proliferation Clinical implications 2 12 2008 Horm Res I989:32(suppl l...
Journal Articles
Hormone Research (1989) 32 (Suppl. 1): 181–182.
Published Online: 02 December 2008
...H.J. Stewart The question of which breast cancer patients to treat has been addressed by reviewing posters presented at the International Symposium on Endocrine Therapy. To date, tamoxifen therapy is the dominant type of adjuvant treatment in postmenopausal patients. The most promising results have...
Journal Articles
Hormone Research (1989) 32 (Suppl. 1): 250–253.
Published Online: 02 December 2008
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Breast cancer Proto-oncogenes Progesterone receptor gene RB-1 gene Organisation...
Journal Articles
Hormone Research (1989) 32 (Suppl. 1): 169–172.
Published Online: 02 December 2008
...H.T. Mouridsen Currently, available data suggest that patients with primary breast cancer, who are postmenopausal, node-positive and with receptor-positive tumours, should be offered adjuvant tamoxifen treatment. In other subgroups of patients with breast cancer, including premenopausal women, data...
Journal Articles
Hormone Research (1989) 32 (Suppl. 1): 183–184.
Published Online: 02 December 2008
...M. Baum Posters presented at the International Symposium on Endocrine Therapy are reviewed to address the question of which adjuvant treatment should be used for early breast cancer. 2 12 2008 © 1989 S. Karger AG, Basel 1989 Copyright / Drug Dosage / Disclaimer Copyright: All rights...
Journal Articles
Hormone Research (1989) 32 (Suppl. 1): 266–269.
Published Online: 02 December 2008
...S.J. Leinster Particles containing reverse transcriptase activity have been detected in metastatic cells. This suggests that there may be viral particles within the primary tumour. The concept that this virus is oncogenic, and is an aetiological agent in breast cancer is attractive, although...
Journal Articles
Journal Articles
Hormone Research (1987) 28 (2-4): 196–201.
Published Online: 28 November 2008
...Henri Rochefort The mechanism of the antiproliferative effect of nonsteroidal antiestrogens (tamoxifen, hydroxytamoxifen) is discussed from studies performed in human breast cancer cell lines. At least two types of mechanism have been evidenced. In the presence of estrogens, antiestrogens behave...
Journal Articles
Hormone Research (1987) 28 (2-4): 212–218.
Published Online: 28 November 2008
...P. Mauvais-Jarvis; F. Kuttenn; A. Gompel This review analyzes recent data from international literature concerning the antiestrogen action of progesterone and progestins at the level of mammary cells in culture from either breast cancer lines or normal breast obtained from reduction mammoplasties...
Journal Articles
Hormone Research (1977) 8 (2): 107–116.
Published Online: 25 November 2008
...F.A.G. Teulings; H.A. van Gilse Tumor regression is sometimes observed during glucocorticoid treatment of patients with breast cancer. The possibility of a direct tumor-growth-suppressing effect, mediated by steroid-hormone receptors, cannot be excluded. A 3 H-dexamethasone-binding component...
Journal Articles
Journal Articles
Hormone Research (2004) 62 (Suppl. 1): 108–115.
Published Online: 10 March 2005
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2005 Acromegaly Breast cancer Colorectal cancer GH/IGF-I axis Insulin-like growth factor I Prostate cancer In non-acromegalic patients...
Journal Articles
Hormone Research (2003) 60 (Suppl. 3): 50.
Published Online: 17 November 2004
...Annie J. Sasco Extended Abstract The most recent estimate of the overall worldwide burden of cancer is that in the year 2000 more than 10 million new cancer cases occurred and approximately 6 million cancer deaths. Breast cancer accounts for about 1 in 10 cancers and is the most frequent cancer...
Journal Articles
Hormone Research (1999) 51 (Suppl. 3): 42–51.
Published Online: 17 November 2004
...Melanie Shim; Pinchas Cohen Perturbations of the insulin-like growth factor (IGF) axis, including the autocrine production of IGFs, IGF binding proteins (IGFBPs) and IGFBP proteases such as prostate specific antigen (PSA), and cathepsin D have been identified in prostate, lung and breast cancer...
Journal Articles
Hormone Research (2000) 53 (Suppl. 3): 25–29.
Published Online: 17 November 2004
... reduction in the incidence of new breast cancer. The compound is similar to placebo in its uterine effects, and similar to oestrogen in causing a two- to threefold increase in the risk of venous thromboembolism. Its lipid effects are similar to those of oestrogen, except for a relatively small effect...
Journal Articles